Evidence map›Paper›PMID 38388701›Full record

ReviewNature reviews. Disease primers2024

Attention-deficit/hyperactivity disorder.

Stephen V Faraone, Mark A Bellgrove, Isabell Brikell, Samuele Cortese, Catharina A Hartman, Chris Hollis, Jeffrey H Newcorn, Alexandra Philipsen, Guilherme V Polanczyk, Katya Rubia and 2 more

Erratum issued Registry-linked trialOpen access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Disease primers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06376331 (Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder and Its Comorbidities), which is not on this map. Cited by 167 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
167citing papers in PubMed, 14 pooled it
88.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06376331 phase1recruitingnot on this map

Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder and Its Comorbidities

TypeinterventionalSponsorThe Second Hospital of Nanjing Medical UniversityRan2024 to 2027Enrolled50ConditionsAttention-deficit/Hyperactivity DisorderArmswashed microbiota transplantation
3 · Its place in the literature

Who cites it

167 citing papers in PubMed, 14 syntheses or guidelines pooled it, 231 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. ADHD and Sex Hormones in Females: A Systematic Review.Journal of attention disorders · 2025
    Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Effectiveness ofPsychological medicine · 2026
    Trial
  20. Trial

107 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 12 institutions in 10 countries.

Stephen V FaraoneDepartments of Psychiatry and of Neuroscience and Physiology, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA. svfaraone@upstate.edu.ORCID http://orcid.org/0000-0002-9217-3982
Mark A BellgroveSchool of Psychological Sciences, Turner Institute for Brain and Mental Health, Monash University, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-0186-8349
Isabell BrikellDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Samuele CorteseCentre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.
Catharina A HartmanInterdisciplinary Center Psychopathology and Emotion regulation (ICPE), Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Chris HollisNational Institute for Health and Care Research (NIHR) MindTech MedTech Co-operative and NIHR Nottingham Biomedical Research Centre, Institute of Mental Health, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.ORCID http://orcid.org/0000-0003-1083-6744
Jeffrey H NewcornDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Alexandra PhilipsenDepartment of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0001-6876-518X
Guilherme V PolanczykDepartment of Psychiatry, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-2311-3289
Katya RubiaDepartment of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neurosciences, King's College London, London, UK.
Margaret H SibleyUniversity of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-7167-2240
Jan K BuitelaarDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, Netherlands.ORCID http://orcid.org/0000-0001-8288-7757
Aarhus University · DKIcahn School of Medicine at Mount Sinai · USKing's College London · GBMonash University · AURadboud University Nijmegen · NLSolent NHS Trust · GBSUNY Upstate Medical University · USUniversidade de São Paulo · BRUniversity Hospital Bonn · DEUniversity Medical Center Groningen · NLUniversity of Nottingham · GBUniversity of Washington · US

Funding

Medical Research Council G0300155Medical Research Council MR/P012647/1
6 · The paper itself

Abstract

Attention-deficit/hyperactivity disorder (ADHD; also known as hyperkinetic disorder) is a common neurodevelopmental condition that affects children and adults worldwide. ADHD has a predominantly genetic aetiology that involves common and rare genetic variants. Some environmental correlates of the disorder have been discovered but causation has been difficult to establish. The heterogeneity of the condition is evident in the diverse presentation of symptoms and levels of impairment, the numerous co-occurring mental and physical conditions, the various domains of neurocognitive impairment, and extensive minor structural and functional brain differences. The diagnosis of ADHD is reliable and valid when evaluated with standard diagnostic criteria. Curative treatments for ADHD do not exist but evidence-based treatments substantially reduce symptoms and/or functional impairment. Medications are effective for core symptoms and are usually well tolerated. Some non-pharmacological treatments are valuable, especially for improving adaptive functioning. Clinical and neurobiological research is ongoing and could lead to the creation of personalized diagnostic and therapeutic approaches for this disorder.

Indexed as

Attention Deficit Disorder with HyperactivityAdultBrainChildHumans

Identifiers

PMID38388701
OpenAlexW4392057793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.